Crossmark

Development of Human Recombinant Antibodies Against ROR1 Tumor Antigen

Crossref DOI link: https://doi.org/10.61186/rbmb.11.2.282

Published Online: 2022-08-01

Update policy: https://doi.org/10.61186/crossmark-policy

Authors

Bemani, Peyman

Moazen, Setareh

Nadimi, Elham

Nejatollahi, Foroogh
License Information

Version of Record valid from 2015-08-13
More Information

Journal Owner: Reports of Biochemistry and Molecular Biology

Journal Publisher: Apex Publishing